Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): one-year follow up results of a randomized controlled trial.
Laurène MansyAgnès CailleMartine Reynaud-GaubertJulien BermudezPhilippe BonniaudRaphael BoriePierre-Yves BrilletJacques CadranelIsabelle Court-FortuneBruno CrestaniMarie-Pierre DebrayMathilde DuprezAnne GuillaumotSandrine Hirschi-SantelmoDominique Israel-BietStéphane JouneauKarine JuvinMallorie KerjouanJulie MankikianCharles Hugo MarquetteJean-Marc NaccacheHilario NunesLaurent PlantierGrégoire PrevotSébastien QuetantJulie TracletVictor ValentinYurdagul UzunhanLidwine Wémeau-StervinouVincent CottinSylvain Marchand-Adamnull nullPublished in: The European respiratory journal (2024)